This site is my collection of updates, statistics and analysis on intellectual property in Canada. I am a partner at DLA Piper (Canada) LLP practicing in the area of intellectual property (more about me). Material on this website are my own views and do not reflect the position of DLA Piper (Canada) LLP, any of its member firms around the world, or any of its clients. IPPractice.ca grew out of my hobby to gather and share interesting updates on intellectual property to friends and colleagues. Highlights include:
Recent Posts:
Amendments to the Federal Courts Rules, primarily to update the Tariff B regime for cost awards, are coming into force later this month. The amendments introduce a new Tariff B that has three columns, more litigation steps and more units. The Rules Committee estimates it will increase cost awards by about 25% “thereby aligning the tariff more closely with the amounts typically awarded under the ‘lump sum’ approach” and provide a “more consistent and predictable regime.” The changes also replace remaining references to “Prothonotary” with “Associate Judge”. …Read More
As of today, patentees who have obtained patents granted after December 1, 2025 can request additional term. A new Chapter 32 in MOPOP addresses the procedures for requesting additional patent term.
The webcast from the October 9th Supreme Court of Canada hearing in Pharmascience Inc. v. Janssen Inc. on patentability of methods of medical treatment is now available online.
The Patent Office has announced a maintenance outage of the MyCIPO Patents portal both this weekend (4pm ET Friday to 10pm ET Sunday) and next weekend (8pm ET Friday to 4pm ET Sunday).
The government released its Budget 2025 today. Some intellectual property related items include: immediate expensing of productivity-enhancing assets including patents; extensions to the Elevate IP program, the Innovation Asset Collective’s Patent Collective and the IP Assist Program; modernization the Patented Medicines Prices Review Board; and amendments to the Copyright Act to create an Artist’s Resale Right.